Showing results (81-90 of 184) with videos related to
Sort By:
Pageof 19
Journal of Lipid Mediators and Cell Signalling|March 1, 1994
Arachidonate metabolism in ischemia-reperfusion associated with pancreas transplantationG Hotter, D Closa, F Pi, et al.Journal of Lipid Mediators and Cell Signalling|March 1, 1994
Fatty acids and cell signal transductionR Graber, C Sumida, E A NunezJournal of Lipid Mediators and Cell Signalling|February 12, 1998
Enhanced hepatic fatty acid oxidation and upregulated carnitine palmitoyltransferase II gene expression by methyl 3-thiaoctadeca-6,9,12,15-tetraenoate in ratsN Willumsen, H Vaagenes, A C Rustan, et al.Journal of Lipid Mediators and Cell Signalling|September 26, 1997
Pharmacological evidence for the putative existence of two different subtypes of PAF receptors on platelets and leukocytes; studies with yangambinJ M Herbert, H C Castro-Faria-Neto, J M Barbosa-Filho, et al.Journal of Lipid Mediators and Cell Signalling|April 3, 1998
Possible mechanisms for the differential effects of high linoleate safflower oil and high alpha-linolenate perilla oil diets on platelet-activating factor production by rat polymorphonuclear leukocytesK Oh-hashi, T Takahashi, S Watanabe, et al.Journal of Lipid Mediators and Cell Signalling|March 1, 1997
Effects of eicosanoids on parameters in isolated rat hepatocytes and isolated rat hepatocyte couplets: protective effects of eicosanoid receptor antagonistsS M Hutchinson, T G Hammond, R Coleman, et al.Journal of Lipid Mediators and Cell Signalling|May 1, 1997
Chronic hyperinsulinemia inhibits platelet-activating factor (PAF) biosynthesis in the rat kidneyG B Kudolo, S J Koopmans, J R Haywood, et al.Journal of Lipid Mediators and Cell Signalling|December 1, 1996
Protein kinase C inhibitors and PAF stimulate phosphatidylserine synthesis in human leucocytesB Bleivik, L R White, K S BjerveJournal of Lipid Mediators and Cell Signalling|January 1, 1997
Design and modeling of new platelet-activating factor antagonists. 2. Synthesis and biological activity of 1,4-bis-(3',4',5'-trimethoxybenzoyl)-2-alkyl and 2-alkyloxymethylpiperazinesF Tavet, A Lamouri, F Heymans, et al.Journal of Lipid Mediators and Cell Signalling|January 1, 1997
Design and modeling of new platelet-activating factor antagonists. 3. Relative importance of hydrophobicity and electronic distribution in piperazinic seriesF Heymans, G Dive, A Lamouri, et al.Pageof 19